Authors:
Ehlert, FA
Cannom, DS
Renfroe, EG
Greene, HL
Ledingham, R
Mitchell, LB
Anderson, JL
Halperin, BD
Herre, JM
Luceri, RM
Marinchak, RA
Steinberg, JS
Citation: Fa. Ehlert et al., Comparison of dilated cardiomyopathy and coronary artery disease in patients with life-threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry, AM HEART J, 142(5), 2001, pp. 816-822
Citation: Jm. Herre et al., Cardiac pacemakers in the transplanted heart: short term with the biatrialanastomosis and unnecessary with the bicaval anastomosis, CURR OPIN C, 15(2), 2000, pp. 115-120
Authors:
Hallstrom, AP
Anderson, JL
Cobb, LA
Friedman, PL
Herre, JM
Klein, RC
McAnulty, J
Steinberg, JS
Citation: Ap. Hallstrom et al., Advantages and disadvantages of trial designs: A review of analysis methods for ICD studies, PACE, 23(6), 2000, pp. 1029-1038
Authors:
Fogel, RI
Herre, JM
Kopelman, HA
Kowey, PR
Trohman, RG
Fineberg, N
Prystowsky, EN
Citation: Ri. Fogel et al., Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias, AM HEART J, 139(4), 2000, pp. 690-695
Authors:
Epstein, AE
Powell, J
Yao, Q
Ocampo, C
Lancaster, S
Rosenberg, Y
Cannom, DS
Herre, JM
Greene, HL
Citation: Ae. Epstein et al., In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival - Results from the AVID Registry, J AM COL C, 34(4), 1999, pp. 1111-1116